Small molecules aiming at the G-H loop of EFNA1 and the ligand binding domain of EPHA2, such as lithocholic acid and the SWL peptide, have also been screened but remained to be tested for tumor treatment [47, 48]. This evidence concerns the gene EPHA2 and neoplasm.